A retrospective cohort study suggested that people with color blindness may have a higher risk of mortality from bladder cancer compared with those who can see colors. The researchers hypothesized ...
In patients with very high risk, high grade T1 with CIS NMIBC, the possible value of adding immune checkpoint blockade to BCG has not been defined.
Real-world effectiveness and treatment patterns in patients with locally advanced or metastatic urothelial carcinoma receiving avelumab first-line maintenance in Japan: Long term follow-up from the ...
MedPage Today on MSN
Major complete response rate in very high-risk bladder cancer with combo treatment
Only three of 37 patients did not achieve CR at 6 months with pembrolizumab and BCG ...
Immunocompromised patients with bladder had a higher risk of disease progression and recurrence when compared to their non-immunocompromised counterparts. Immunocompromised patients with bladder ...
A research team led by Oh Jong-jin, a urology professor at Seoul National University Bundang Hospital in Seongnam, said ...
Also Read: ImmunityBio Slapped With FDA Refusal To File Letter For Expanded Use Of Its Bladder Cancer Drug Specific key efficacy findings from cohort B (N=80) of the Phase 2/3 open-label, single-arm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results